Five Prime Thera (FPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FPRX | CLDX | UPB | ||
| Company | Five Prime Thera | Celldex Therapeutics | Upstream Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 37.99 | 27.13 | 30.27 | ||
| High | 38.01 | 27.42 | 30.76 | ||
| Low | 37.95 | 26.22 | 29.05 | ||
| Latest | 38.00 | 26.58 | 29.21 | ||
| Change | +0.01 | -0.69 | -1.22 | ||
| % Change | +0.03% | -2.53% | -4.01% | ||
| Volume | 1,006,600 | 463,600 | 347,200 | ||
| 20-Day Average Volume | 1,554,540 | 766,525 | 598,545 | ||
| Previous Close | 37.99 | 27.27 | 30.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.83 | 27.28 | 28.31 | ||
| 20-Day Raw Stochastic | 97.56% | 29.10% | 54.83% | ||
| 20-Day Relative Strength | 72.91 | 50.41 | 57.98 | ||
| Weighted Alpha | +62.34 | +11.17 | +130.40 | ||
| Today's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 96% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.29% since 04/08/21 | -0.37% since 12/16/25 | -0.38% since 12/16/25 | ||
| Low | 37.90 on 04/09/21 | 24.97 on 12/18/25 | 28.15 on 12/17/25 | ||
| High | 38.01 on 04/15/21 | 27.92 on 12/22/25 | 30.89 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +0.37% since 03/15/21 | +2.55% since 11/21/25 | +14.32% since 11/21/25 | ||
| Low | 37.60 on 04/05/21 | 24.97 on 12/18/25 | 24.61 on 12/02/25 | ||
| High | 38.01 on 04/15/21 | 30.50 on 12/08/25 | 33.00 on 11/26/25 | ||
| 3-Month | |||||
| %Chg | +167.23% since 01/15/21 | +9.70% since 09/23/25 | +79.42% since 09/23/25 | ||
| Low | 13.63 on 01/21/21 | 22.10 on 11/11/25 | 16.02 on 09/25/25 | ||
| High | 38.90 on 03/09/21 | 30.50 on 12/08/25 | 33.00 on 11/26/25 | ||
| 6-Month | |||||
| %Chg | +551.80% since 10/15/20 | +30.36% since 06/23/25 | +172.48% since 06/23/25 | ||
| Low | 4.50 on 11/04/20 | 19.52 on 06/30/25 | 10.54 on 07/22/25 | ||
| High | 38.90 on 03/09/21 | 30.50 on 12/08/25 | 33.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,769,736 | 1,812,064 | 1,644,407 | ||
| Shares Outstanding, K | 46,572 | 66,449 | 54,039 | ||
| Annual Sales | 13,180,000 | 7,020,000 | 2,370,000 | ||
| Annual Net Income | -84,330,000 | -157,860,000 | -62,810,000 | ||
| Last Quarter Sales | -710,000 | 730,000 | 680,000 | ||
| Last Quarter Net Income | -20,850,000 | -56,600,000 | -33,750,000 | ||
| 60-Month Beta | 4.63 | 1.13 | 1.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.01 on 11/10/25 | -0.63 on 11/05/25 | ||
| Latest Earnings Date | 05/06/21 | 02/26/26 | 03/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||